Search Results 2711-2720 of 13648 for monoclonal antibody

1. Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (ReSPECT) - Mayo Clinic

   Subjects with unknown HIV status should be tested for HIV antibodies per standard of care. 20. Pregnant or lactating females. 21. The Principal Investigator ...

2. A pivotal study of derazantinib in patients with inoperable or advanced intrahepatic cholangiocarcinoma and FGFR2 gene fusions or FGFR2 gene mutations or amplifications - Mayo Clinic

   One chemotherapy or biological (e.g., antibody) cycle interval;; Five half-lives of any small-molecule investigational or licensed medicinal product;; Two ...

3. Clinical trials - Oncology (Medical)

   ... antibodies) treatment, CPI-naïve hepatocellular carcinoma (HCC), and treatment-naïve endometrioid endometrial cancer. Accelerated vs Standard BEP ...

4. A Study of XMT-1660 in Participants With Solid Tumors - Mayo Clinic

   * Prior treatment with an Antibody Drug Conjugate (ADC) containing an auristatin payload. Prior treatment with another ADC containing other payloads is ...

5. Efficacy, Safety, Tolerability, Pharmacodynamics, And Pharmacokinetics Of BIA 28-6156 In GBA-PD - Mayo Clinic

   The subject has a positive test result for hepatitis B surface antigen (HBsAg), hepatitis C virus antibody (anti-HCV), or human immunodeficiency virus 1 ...

6. Sonocloud-9 In Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU Or TMZ) In Recurrent GBM - Mayo Clinic

   * For biologics (e.g., antibodies, except bevacizumab) 2. ≥ 6 weeks of prior bevacizumab 9. Adequate hematologic, hepatic, and renal laboratory values ...

7. Clinical trials - Oncology (Medical)

   ... antibodies) treatment, CPI-naïve hepatocellular carcinoma (HCC), and treatment-naïve endometrioid endometrial cancer. Accelerated vs Standard BEP ...

8. Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed By Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance In Treatment-Naïve Mantle Cell Lymphoma - Mayo Clinic

   Patients with presence of HCV antibody are eligible if HCV RNA is undetectable (NOTE: the limit of detection for HCV RNA must have a sensitivity of < 15 IU/mL).

9. Cellular Therapy Clinical Trials - Mayo Clinic Research

   ... antibodies. This is highly significant as one of the ... Adipose-Derived ... antibody (ANCA) associated vasculitis using primary samples and/or patient ...

10. A Study to Assess Subcutaneous Lirentelimab (AK002) in Chronic Spontaneous Urticaria - Mayo Clinic

    similar chemical classes (i.e., murine, chimeric or human antibodies). 2. Current use of biologics for any indication. 3. Demonstrated lack of primary ...